CollabRx Snags ASCO Partnership

Xconomy San Francisco — 

Palo Alto, CA-based CollabRx, a developer of web-based applications to help connect cancer patients and researchers, is announcing today it has formed a partnership with the largest association of cancer physicians—the American Society of Clinical Oncology. Under the collaboration, ASCO will provide CollabRx with access to all its published content, and make CollabRx’s Targeted Therapy Finder available online to its 30,000 members. CollabRx’s first app is designed to help personalize treatment options for patients with melanoma, a deadly form of skin cancer. I wrote about CollabRx founder Jay “Marty” Tenenbaum, and his quest to better connect patients and researchers, in a feature about an open source database called Cancer Commons.